Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV

Johann Wolfgang Goethe University Hospital

Overview

This study will evaluate the effectiveness of Acoustic Radiation Force Impulse (ARFI)- Imaging compared to Transient Elastography (FibroScan) in differentiating liver fibrosis in patients with chronic hepatitis C. Patients who are scheduled to have a liver biopsy will also undergo ARFI and FibroScan testing. The liver biopsy will be used as the reference method. The target sample size is 433.

Study Type

INTERVENTIONAL

Purpose

DIAGNOSTIC

Conditions

Chronic Hepatitis C

Interventions

FibroScanDEVICE

Acoustic Radiation Force Impulse (ARFI)- ImagingDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 79 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Male or female, 18-79 years old * Written consent * Chronic Hepatitis C infection * Liver biopsy planned or performed within the last six months * In addition, 10 patients/center with proven liver cirrhosis without present liver biopsy can be included Exclusion Criteria: * Consuming illness (HIV infection, malignoma) * Comorbidities associated to HCV (HBV, NASH, hemochromatosis, primary sclerosing cholangitis, primary biliary cirrhosis * Antiviral therapy between liver biopsy and study inclusion * Pacemaker or heart defibrillator * Pregnancy or lactation * Liver transplantation

Locations (9)

Bordeaux University Hospital

Bordeaux, France

Universitätsklinikum Düsseldorf

Düsseldorf, Germany

Universitätsklinikum Erlangen

Erlangen, Germany

Klinikum der J.W. Goethe-Universität

Frankfurt am Main, Germany

Outcomes

Primary Outcomes

Non-inferiority of AUROCs of Acoustic Radiation Force Impulse (ARFI)- Imaging to Transient Elastography (Fibroscan) for assessment of liver fibrosis in patients with chronic hepatitis C using liver biopsy as the reference standard.

The diagnostic accuracy measured with the Area under the ROC curve (AUROC) is calculated for Acoustic Radiation Force Impulse (ARFI)- Imaging and Transient Elastography (Fibroscan) using histology obtained by liver biopsy as reference method in patients infected with chronic hepatitis C. The ROC curve represents sensitivity versus 1-specificity for all possible cut-off values for prediction of the different fibrosis stages, respectively. The areas under the curves (AUROC) as well as 95 % CI of AUROC are calculated.

Secondary Outcomes

Comparison of AUROC of ARFI-Imaging and Transient Elastography with FibroMax (liver fibrosis marker)

Comparison of AUROC of ARFI and Transient Elastography with the European Liver Fibrosis-Group Marker (ELF)

Evaluation of a combination of non-invasive methods for optimising AUROC for the assessment of liver fibrosis

Evaluation of factors associated with measurement failure of ARFI-Imaging and Transient Elastography

Assessment of center variability of results

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.